Vericel
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 3 days.
- Recent price momentum is +44.3% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 10.5% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 02:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation D
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 89.9x | Better than 5% |
| Forward P/E | 62.6x | Better than 5% |
| Price / Sales | 9.0x | Better than 12% |
| P/E vs own 5-yr range | 50th pctl | Better than 59% |
Growth A
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 18.9% | Better than 81% |
| Free cash flow CAGR (3Y) | 34.9% | Better than 77% |
Profitability C+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 74.4% | Better than 86% |
| Operating margin | 4.0% | Better than 32% |
| Net margin | 6.0% | Better than 47% |
| Return on equity | 5.1% | Better than 37% |
| Return on invested capital | 2.5% | Better than 35% |
Momentum A
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 34.8% | Better than 99% |
| 6-month return | 65.6% | Better than 97% |
| 12-month return (ex latest month) | 7.5% | Better than 43% |
| Distance below 52-week high | 3.7% | Better than 96% |
Financial Health A
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 5.0x | Better than 86% |
| Debt to assets | 19.7% | Better than 56% |
| Interest coverage | 28.6x | Better than 86% |
| Free cash flow / net income | 149.8% | Better than 65% |
Analyst View C+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 83.3% | Better than 63% |
| Upside to average target | 15.1% | Better than 23% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 58.26
- Open
- 58.11
- Day range
- 57.33 - 59.49
- Avg price
- 57.99
- Volume
- 582.34K
- Turnover
- 33.77M
- Turnover ratei
- 1.16%
- Volume ratioi
- 0.78
- Amplitudei
- 3.70%
- 52-week rangei
- 28.95 - 59.75
Valuation
- P/Ei
- 179.75
- P/E (TTM)i
- 89.88
- P/Bi
- 7.64
- EPSi
- 0.32
- Book value / shi
- 7.53
- Net profit
- 16.33M
- Net assets
- 384.15M
Share structure
- Market cap
- 2.94B
- Float capi
- 2.90B
- Shares out
- 51.03M
- Float sharesi
- 50.40M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
3.7% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+1.00M net over the window
Short interest
- Shares short
- 5.36M
- % of floati
- 10.48%
- Days to coveri
- 9.83
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Vericel (VCEL)?
Vericel last traded at 57.52. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Vericel's market cap?
About 2.94B.
What is the P/E ratio of Vericel?
The trailing twelve-month P/E is 89.88, below its own 5-year average of 719.71 — in the middle of its historical range (50.16% percentile). See the Valuation tab for the full history.
Does Vericel pay a dividend?
Vericel does not currently pay a regular dividend.
Is Vericel a buy according to analysts?
The consensus of 6 analysts is a Buy rating, with an average 12-month price target of 66.20, which implies 15.1% upside from the current price. This is not investment advice.
What is Vericel's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Vericel a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Vericel discussion 0 comments